

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.09799997 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.09799997 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.87861389 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.87861389 |
| 5 | glyoxylate metabolic process (GO:0046487) | 6.65416986 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.64411981 |
| 7 | lysine catabolic process (GO:0006554) | 6.56740922 |
| 8 | lysine metabolic process (GO:0006553) | 6.56740922 |
| 9 | urate metabolic process (GO:0046415) | 6.50361956 |
| 10 | drug transmembrane transport (GO:0006855) | 6.50048074 |
| 11 | cysteine metabolic process (GO:0006534) | 6.48142928 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 6.25236951 |
| 13 | tryptophan catabolic process (GO:0006569) | 6.25236951 |
| 14 | indole-containing compound catabolic process (GO:0042436) | 6.25236951 |
| 15 | actin-myosin filament sliding (GO:0033275) | 6.17955435 |
| 16 | muscle filament sliding (GO:0030049) | 6.17955435 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.89882259 |
| 18 | creatine metabolic process (GO:0006600) | 5.72944040 |
| 19 | kynurenine metabolic process (GO:0070189) | 5.70265266 |
| 20 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.58107520 |
| 21 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.58015600 |
| 22 | NADH metabolic process (GO:0006734) | 5.48116872 |
| 23 | drug transport (GO:0015893) | 5.38027820 |
| 24 | serine family amino acid catabolic process (GO:0009071) | 5.33547932 |
| 25 | drug catabolic process (GO:0042737) | 5.30431832 |
| 26 | bile acid biosynthetic process (GO:0006699) | 5.18768559 |
| 27 | exogenous drug catabolic process (GO:0042738) | 5.14714259 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 5.09733790 |
| 29 | homocysteine metabolic process (GO:0050667) | 5.07970069 |
| 30 | amino-acid betaine metabolic process (GO:0006577) | 4.98399187 |
| 31 | actin-mediated cell contraction (GO:0070252) | 4.97132969 |
| 32 | skeletal muscle contraction (GO:0003009) | 4.95512561 |
| 33 | epoxygenase P450 pathway (GO:0019373) | 4.89225025 |
| 34 | aromatic amino acid family metabolic process (GO:0009072) | 4.85939610 |
| 35 | short-chain fatty acid metabolic process (GO:0046459) | 4.84009314 |
| 36 | oxaloacetate metabolic process (GO:0006107) | 4.72763891 |
| 37 | aspartate family amino acid catabolic process (GO:0009068) | 4.71328277 |
| 38 | cellular ketone body metabolic process (GO:0046950) | 4.70350982 |
| 39 | alpha-amino acid catabolic process (GO:1901606) | 4.67239871 |
| 40 | cellular modified amino acid catabolic process (GO:0042219) | 4.66785304 |
| 41 | serine family amino acid metabolic process (GO:0009069) | 4.66658656 |
| 42 | alpha-linolenic acid metabolic process (GO:0036109) | 4.55108760 |
| 43 | ethanol metabolic process (GO:0006067) | 4.49493376 |
| 44 | cellular amino acid catabolic process (GO:0009063) | 4.48772572 |
| 45 | regulation of skeletal muscle contraction (GO:0014819) | 4.47738476 |
| 46 | indolalkylamine metabolic process (GO:0006586) | 4.45888349 |
| 47 | organic cation transport (GO:0015695) | 4.45510959 |
| 48 | glutamate metabolic process (GO:0006536) | 4.43155616 |
| 49 | urea cycle (GO:0000050) | 4.37856113 |
| 50 | urea metabolic process (GO:0019627) | 4.37856113 |
| 51 | acetyl-CoA metabolic process (GO:0006084) | 4.35550051 |
| 52 | valine metabolic process (GO:0006573) | 4.32672100 |
| 53 | 2-oxoglutarate metabolic process (GO:0006103) | 4.32420157 |
| 54 | fatty acid beta-oxidation (GO:0006635) | 4.29410917 |
| 55 | bile acid metabolic process (GO:0008206) | 4.27329325 |
| 56 | response to mercury ion (GO:0046689) | 4.26241676 |
| 57 | cellular biogenic amine catabolic process (GO:0042402) | 4.25663194 |
| 58 | amine catabolic process (GO:0009310) | 4.25663194 |
| 59 | omega-hydroxylase P450 pathway (GO:0097267) | 4.25133792 |
| 60 | benzene-containing compound metabolic process (GO:0042537) | 4.24771720 |
| 61 | striated muscle contraction (GO:0006941) | 4.21502950 |
| 62 | branched-chain amino acid metabolic process (GO:0009081) | 4.20403224 |
| 63 | tyrosine metabolic process (GO:0006570) | 4.19751160 |
| 64 | phosphate ion transport (GO:0006817) | 4.17712762 |
| 65 | fatty acid oxidation (GO:0019395) | 4.14977065 |
| 66 | serine family amino acid biosynthetic process (GO:0009070) | 4.14740945 |
| 67 | nitrogen cycle metabolic process (GO:0071941) | 4.11716540 |
| 68 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.10018409 |
| 69 | sarcomere organization (GO:0045214) | 4.09399904 |
| 70 | lipid oxidation (GO:0034440) | 4.07454673 |
| 71 | ketone body metabolic process (GO:1902224) | 4.06090690 |
| 72 | myofibril assembly (GO:0030239) | 4.05261355 |
| 73 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.04236968 |
| 74 | carboxylic acid catabolic process (GO:0046395) | 4.03447040 |
| 75 | organic acid catabolic process (GO:0016054) | 4.03447040 |
| 76 | quaternary ammonium group transport (GO:0015697) | 4.03071100 |
| 77 | coenzyme catabolic process (GO:0009109) | 4.02333129 |
| 78 | cellular glucuronidation (GO:0052695) | 4.01408928 |
| 79 | carnitine metabolic process (GO:0009437) | 3.99510943 |
| 80 | complement activation, alternative pathway (GO:0006957) | 3.99152560 |
| 81 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.98655205 |
| 82 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.98433253 |
| 83 | regulation of relaxation of muscle (GO:1901077) | 3.98378816 |
| 84 | ethanol oxidation (GO:0006069) | 3.97110203 |
| 85 | branched-chain amino acid catabolic process (GO:0009083) | 3.95582588 |
| 86 | fatty acid catabolic process (GO:0009062) | 3.92825093 |
| 87 | tricarboxylic acid metabolic process (GO:0072350) | 3.90577544 |
| 88 | protein carboxylation (GO:0018214) | 3.89996844 |
| 89 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.89996844 |
| 90 | cardiac muscle contraction (GO:0060048) | 3.88794138 |
| 91 | monocarboxylic acid catabolic process (GO:0072329) | 3.87958677 |
| 92 | aldehyde catabolic process (GO:0046185) | 3.87114663 |
| 93 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.87096999 |
| 94 | phosphate ion transmembrane transport (GO:0035435) | 3.86613233 |
| 95 | carnitine shuttle (GO:0006853) | 3.83575270 |
| 96 | glucuronate metabolic process (GO:0019585) | 3.82676410 |
| 97 | uronic acid metabolic process (GO:0006063) | 3.82676410 |
| 98 | regulation of protein activation cascade (GO:2000257) | 3.81970166 |
| 99 | actin filament-based movement (GO:0030048) | 3.78461898 |
| 100 | glycine metabolic process (GO:0006544) | 3.76006909 |
| 101 | fatty acid transmembrane transport (GO:1902001) | 3.73737569 |
| 102 | negative regulation of fibrinolysis (GO:0051918) | 3.72841333 |
| 103 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.72712949 |
| 104 | glycogen catabolic process (GO:0005980) | 3.71571879 |
| 105 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.65374019 |
| 106 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.65374019 |
| 107 | regulation of complement activation (GO:0030449) | 3.61130359 |
| 108 | regulation of sequestering of triglyceride (GO:0010889) | 3.59617009 |
| 109 | gluconeogenesis (GO:0006094) | 3.58422904 |
| 110 | drug metabolic process (GO:0017144) | 3.58248041 |
| 111 | tricarboxylic acid cycle (GO:0006099) | 3.58229696 |
| 112 | cardiac myofibril assembly (GO:0055003) | 3.57201602 |
| 113 | regulation of fibrinolysis (GO:0051917) | 3.55641002 |
| 114 | regulation of cholesterol homeostasis (GO:2000188) | 3.55287920 |
| 115 | indole-containing compound metabolic process (GO:0042430) | 3.52963983 |
| 116 | high-density lipoprotein particle remodeling (GO:0034375) | 3.52467138 |
| 117 | flavonoid metabolic process (GO:0009812) | 3.50393377 |
| 118 | regulation of triglyceride catabolic process (GO:0010896) | 3.49365921 |
| 119 | response to muscle activity (GO:0014850) | 3.48313916 |
| 120 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.47949215 |
| 121 | acylglycerol homeostasis (GO:0055090) | 3.46534914 |
| 122 | triglyceride homeostasis (GO:0070328) | 3.46534914 |
| 123 | small molecule catabolic process (GO:0044282) | 3.44647788 |
| 124 | fructose metabolic process (GO:0006000) | 3.44476686 |
| 125 | glucan catabolic process (GO:0009251) | 3.44205029 |
| 126 | fatty acid homeostasis (GO:0055089) | 3.41766624 |
| 127 | hexose biosynthetic process (GO:0019319) | 3.38655305 |
| 128 | bile acid and bile salt transport (GO:0015721) | 3.38482590 |
| 129 | carnitine transport (GO:0015879) | 3.37402967 |
| 130 | amino-acid betaine transport (GO:0015838) | 3.37402967 |
| 131 | negative regulation of sterol transport (GO:0032372) | 3.36263094 |
| 132 | negative regulation of cholesterol transport (GO:0032375) | 3.36263094 |
| 133 | arginine metabolic process (GO:0006525) | 3.35960263 |
| 134 | dicarboxylic acid metabolic process (GO:0043648) | 3.35237420 |
| 135 | blood coagulation, intrinsic pathway (GO:0007597) | 3.31956980 |
| 136 | regulation of actin filament-based movement (GO:1903115) | 3.28917067 |
| 137 | cellular polysaccharide catabolic process (GO:0044247) | 3.24599877 |
| 138 | cardiac muscle hypertrophy (GO:0003300) | 3.17070442 |
| 139 | regulation of cell communication by electrical coupling (GO:0010649) | 3.15958768 |
| 140 | monosaccharide biosynthetic process (GO:0046364) | 3.13434419 |
| 141 | skeletal muscle fiber development (GO:0048741) | 3.12007478 |
| 142 | fibrinolysis (GO:0042730) | 3.10812352 |
| 143 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.10742887 |
| 144 | muscle contraction (GO:0006936) | 3.10234253 |
| 145 | striated muscle hypertrophy (GO:0014897) | 3.07221860 |
| 146 | skeletal muscle adaptation (GO:0043501) | 3.05552145 |
| 147 | actomyosin structure organization (GO:0031032) | 3.02973030 |
| 148 | regulation of cholesterol esterification (GO:0010872) | 3.02249032 |
| 149 | glycogen biosynthetic process (GO:0005978) | 3.02246838 |
| 150 | glucan biosynthetic process (GO:0009250) | 3.02246838 |
| 151 | polysaccharide catabolic process (GO:0000272) | 2.93898957 |
| 152 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.93805192 |
| 153 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.93033749 |
| 154 | regulation of plasminogen activation (GO:0010755) | 2.93008582 |
| 155 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.91356401 |
| 156 | acylglycerol catabolic process (GO:0046464) | 2.90980444 |
| 157 | neutral lipid catabolic process (GO:0046461) | 2.90980444 |
| 158 | acute-phase response (GO:0006953) | 2.90424118 |
| 159 | triglyceride catabolic process (GO:0019433) | 2.89552003 |
| 160 | carnitine transmembrane transport (GO:1902603) | 2.89513122 |
| 161 | positive regulation of lipid catabolic process (GO:0050996) | 2.88220775 |
| 162 | macromolecular complex remodeling (GO:0034367) | 2.87964613 |
| 163 | plasma lipoprotein particle remodeling (GO:0034369) | 2.87964613 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.61438689 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.52286664 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.86501777 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.63295628 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.18081632 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.47246167 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.83658171 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.69307455 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.27315717 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.55738878 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.18409683 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07657498 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.4496491 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.73629630 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.70973046 |
| 16 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.70812329 |
| 17 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61881502 |
| 18 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.59277385 |
| 19 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.58463449 |
| 20 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.55739752 |
| 21 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.53537387 |
| 22 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.51503701 |
| 23 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49501950 |
| 24 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.49109194 |
| 25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.45438819 |
| 26 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.42838020 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.42650923 |
| 28 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.40047173 |
| 29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.39416170 |
| 30 | P68_20966046_ChIP-Seq_HELA_Human | 1.33714455 |
| 31 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.30644029 |
| 32 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.21525786 |
| 33 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.21278385 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.21071331 |
| 35 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.18326340 |
| 36 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.16584037 |
| 37 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.16528185 |
| 38 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.16134965 |
| 39 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.14560007 |
| 40 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.14372589 |
| 41 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.14111703 |
| 42 | SA1_27219007_Chip-Seq_Bcells_Human | 1.13164492 |
| 43 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.12899957 |
| 44 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.12395370 |
| 45 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.10459490 |
| 46 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10165836 |
| 47 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.07806269 |
| 48 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.06383432 |
| 49 | KDM2B_26808549_Chip-Seq_K562_Human | 1.05958508 |
| 50 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05518699 |
| 51 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.05175697 |
| 52 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.02431082 |
| 53 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.02129762 |
| 54 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.02020047 |
| 55 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.99970501 |
| 56 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.99505447 |
| 57 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.99319830 |
| 58 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.96380316 |
| 59 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.95729053 |
| 60 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.95031122 |
| 61 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.94778149 |
| 62 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.94700560 |
| 63 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.94533652 |
| 64 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.93721990 |
| 65 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.93136354 |
| 66 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.91220858 |
| 67 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.89781242 |
| 68 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.89160125 |
| 69 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88824467 |
| 70 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.87685806 |
| 71 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.86776542 |
| 72 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.86351695 |
| 73 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.86318460 |
| 74 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.85714310 |
| 75 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.85495404 |
| 76 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.85319305 |
| 77 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.84689110 |
| 78 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.84000096 |
| 79 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.83932363 |
| 80 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.83732965 |
| 81 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.82694838 |
| 82 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.82685437 |
| 83 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.81912532 |
| 84 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.81898754 |
| 85 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.81881617 |
| 86 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81820638 |
| 87 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81586025 |
| 88 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.81561097 |
| 89 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.80960144 |
| 90 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.80905309 |
| 91 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.79861674 |
| 92 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.79632873 |
| 93 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.79601507 |
| 94 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.79601507 |
| 95 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.79552911 |
| 96 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.78826017 |
| 97 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.77992207 |
| 98 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.76582929 |
| 99 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.76253918 |
| 100 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.75684340 |
| 101 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.74810758 |
| 102 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.73700581 |
| 103 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.73641114 |
| 104 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.72729005 |
| 105 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.71240028 |
| 106 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.69448249 |
| 107 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69272947 |
| 108 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.68981229 |
| 109 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.68475751 |
| 110 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.68169148 |
| 111 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.67346624 |
| 112 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67021525 |
| 113 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.66633245 |
| 114 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.65315577 |
| 115 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65110740 |
| 116 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.63743724 |
| 117 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.63703268 |
| 118 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.63124779 |
| 119 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.63110497 |
| 120 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.62466746 |
| 121 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.62466746 |
| 122 | AR_20517297_ChIP-Seq_VCAP_Human | 0.62237603 |
| 123 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.61940450 |
| 124 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.61332139 |
| 125 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.60449771 |
| 126 | CBP_21632823_ChIP-Seq_H3396_Human | 0.60074613 |
| 127 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.59965002 |
| 128 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.58937477 |
| 129 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.58394638 |
| 130 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.57678995 |
| 131 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.57189520 |
| 132 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.56682763 |
| 133 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.55914591 |
| 134 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.55310240 |
| 135 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.55305384 |
| 136 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.54475113 |
| 137 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.54383127 |
| 138 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.53663095 |
| 139 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53613665 |
| 140 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.52992216 |
| 141 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.52757440 |
| 142 | GATA2_19941826_ChIP-Seq_K562_Human | 0.51822158 |
| 143 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.51753308 |
| 144 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.50919350 |
| 145 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.50793014 |
| 146 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.49944301 |
| 147 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.49519886 |
| 148 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.49490525 |
| 149 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.48401426 |
| 150 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.48182415 |
| 151 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.47747656 |
| 152 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.47741312 |
| 153 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.46839639 |
| 154 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.46703933 |
| 155 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.46569893 |
| 156 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.45303285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 8.08662035 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 7.67880727 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.35218131 |
| 4 | MP0005365_abnormal_bile_salt | 5.23798141 |
| 5 | MP0000751_myopathy | 4.84360240 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.73883682 |
| 7 | MP0005332_abnormal_amino_acid | 3.90773367 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 3.70817272 |
| 9 | MP0003252_abnormal_bile_duct | 3.64634157 |
| 10 | MP0000749_muscle_degeneration | 3.57719409 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 3.52341946 |
| 12 | MP0003195_calcinosis | 3.47624939 |
| 13 | MP0004019_abnormal_vitamin_homeostasis | 3.39308077 |
| 14 | MP0004036_abnormal_muscle_relaxation | 3.21348029 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.97453989 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.74310459 |
| 17 | MP0004043_abnormal_pH_regulation | 2.64904312 |
| 18 | MP0004087_abnormal_muscle_fiber | 2.63847512 |
| 19 | MP0004084_abnormal_cardiac_muscle | 2.61642518 |
| 20 | MP0009643_abnormal_urine_homeostasis | 2.43392569 |
| 21 | MP0002106_abnormal_muscle_physiology | 2.36331180 |
| 22 | MP0001666_abnormal_nutrient_absorption | 2.27239519 |
| 23 | MP0000759_abnormal_skeletal_muscle | 2.22304190 |
| 24 | MP0005083_abnormal_biliary_tract | 2.20365383 |
| 25 | MP0002269_muscular_atrophy | 2.18783502 |
| 26 | MP0002332_abnormal_exercise_endurance | 2.12965318 |
| 27 | MP0009840_abnormal_foam_cell | 2.02616646 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 2.01875606 |
| 29 | MP0004233_abnormal_muscle_weight | 2.00362657 |
| 30 | MP0005369_muscle_phenotype | 1.96601899 |
| 31 | MP0005620_abnormal_muscle_contractility | 1.92215226 |
| 32 | MP0002972_abnormal_cardiac_muscle | 1.89781757 |
| 33 | MP0002118_abnormal_lipid_homeostasis | 1.89435509 |
| 34 | MP0005636_abnormal_mineral_homeostasis | 1.88063504 |
| 35 | MP0005319_abnormal_enzyme/_coenzyme | 1.84297791 |
| 36 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.81008606 |
| 37 | MP0004215_abnormal_myocardial_fiber | 1.79615551 |
| 38 | MP0000609_abnormal_liver_physiology | 1.75376913 |
| 39 | MP0000750_abnormal_muscle_regeneration | 1.69470989 |
| 40 | MP0006138_congestive_heart_failure | 1.68012436 |
| 41 | MP0001765_abnormal_ion_homeostasis | 1.63403797 |
| 42 | MP0004510_myositis | 1.62881545 |
| 43 | MP0001756_abnormal_urination | 1.62013112 |
| 44 | MP0003186_abnormal_redox_activity | 1.59218760 |
| 45 | MP0010630_abnormal_cardiac_muscle | 1.54538813 |
| 46 | MP0001764_abnormal_homeostasis | 1.53851225 |
| 47 | MP0004185_abnormal_adipocyte_glucose | 1.47948686 |
| 48 | MP0005385_cardiovascular_system_phenoty | 1.47755862 |
| 49 | MP0001544_abnormal_cardiovascular_syste | 1.47755862 |
| 50 | MP0003879_abnormal_hair_cell | 1.43490281 |
| 51 | MP0005451_abnormal_body_composition | 1.43016985 |
| 52 | MP0002136_abnormal_kidney_physiology | 1.42954382 |
| 53 | MP0004484_altered_response_of | 1.40392243 |
| 54 | MP0003868_abnormal_feces_composition | 1.33406039 |
| 55 | MP0005670_abnormal_white_adipose | 1.29164977 |
| 56 | MP0002876_abnormal_thyroid_physiology | 1.26482939 |
| 57 | MP0006036_abnormal_mitochondrial_physio | 1.24789694 |
| 58 | MP0005084_abnormal_gallbladder_morpholo | 1.19855189 |
| 59 | MP0009780_abnormal_chondrocyte_physiolo | 1.19150714 |
| 60 | MP0005058_abnormal_lysosome_morphology | 1.14885274 |
| 61 | MP0005535_abnormal_body_temperature | 1.05070706 |
| 62 | MP0002108_abnormal_muscle_morphology | 1.04549770 |
| 63 | MP0000003_abnormal_adipose_tissue | 1.04371822 |
| 64 | MP0003137_abnormal_impulse_conducting | 1.04016225 |
| 65 | MP0009764_decreased_sensitivity_to | 1.00544539 |
| 66 | MP0000598_abnormal_liver_morphology | 0.98631209 |
| 67 | MP0000733_abnormal_muscle_development | 0.95772514 |
| 68 | MP0002127_abnormal_cardiovascular_syste | 0.93989713 |
| 69 | MP0008775_abnormal_heart_ventricle | 0.93165710 |
| 70 | MP0004270_analgesia | 0.93088256 |
| 71 | MP0009642_abnormal_blood_homeostasis | 0.91061187 |
| 72 | MP0000013_abnormal_adipose_tissue | 0.88997377 |
| 73 | MP0005666_abnormal_adipose_tissue | 0.86744623 |
| 74 | MP0001661_extended_life_span | 0.85208696 |
| 75 | MP0002928_abnormal_bile_duct | 0.84839493 |
| 76 | MP0008469_abnormal_protein_level | 0.82701186 |
| 77 | MP0005647_abnormal_sex_gland | 0.81872436 |
| 78 | MP0002078_abnormal_glucose_homeostasis | 0.81708711 |
| 79 | MP0004130_abnormal_muscle_cell | 0.79539882 |
| 80 | MP0000538_abnormal_urinary_bladder | 0.79511457 |
| 81 | MP0005220_abnormal_exocrine_pancreas | 0.79504316 |
| 82 | MP0002837_dystrophic_cardiac_calcinosis | 0.79124247 |
| 83 | MP0000604_amyloidosis | 0.78284039 |
| 84 | MP0002971_abnormal_brown_adipose | 0.75641892 |
| 85 | MP0003221_abnormal_cardiomyocyte_apopto | 0.75283843 |
| 86 | MP0003011_delayed_dark_adaptation | 0.75266084 |
| 87 | MP0000230_abnormal_systemic_arterial | 0.74705776 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 0.72444689 |
| 89 | MP0009763_increased_sensitivity_to | 0.71258615 |
| 90 | MP0003705_abnormal_hypodermis_morpholog | 0.69601482 |
| 91 | MP0003878_abnormal_ear_physiology | 0.69448340 |
| 92 | MP0005377_hearing/vestibular/ear_phenot | 0.69448340 |
| 93 | MP0005408_hypopigmentation | 0.69128628 |
| 94 | MP0002168_other_aberrant_phenotype | 0.68632370 |
| 95 | MP0006035_abnormal_mitochondrial_morpho | 0.67027256 |
| 96 | MP0003329_amyloid_beta_deposits | 0.66343870 |
| 97 | MP0003828_pulmonary_edema | 0.65799959 |
| 98 | MP0008961_abnormal_basal_metabolism | 0.65061947 |
| 99 | MP0005376_homeostasis/metabolism_phenot | 0.64998588 |
| 100 | MP0004858_abnormal_nervous_system | 0.64377728 |
| 101 | MP0005167_abnormal_blood-brain_barrier | 0.63859335 |
| 102 | MP0003638_abnormal_response/metabolism_ | 0.63683364 |
| 103 | MP0009697_abnormal_copulation | 0.63432913 |
| 104 | MP0004085_abnormal_heartbeat | 0.63342271 |
| 105 | MP0001958_emphysema | 0.62877376 |
| 106 | MP0004147_increased_porphyrin_level | 0.62671811 |
| 107 | MP0003690_abnormal_glial_cell | 0.60745819 |
| 108 | MP0005334_abnormal_fat_pad | 0.60680778 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.60299066 |
| 110 | MP0003646_muscle_fatigue | 0.56437367 |
| 111 | MP0005395_other_phenotype | 0.54915708 |
| 112 | MP0005266_abnormal_metabolism | 0.54513158 |
| 113 | MP0002135_abnormal_kidney_morphology | 0.53629945 |
| 114 | MP0002254_reproductive_system_inflammat | 0.53253493 |
| 115 | MP0000343_altered_response_to | 0.51958525 |
| 116 | MP0003953_abnormal_hormone_level | 0.51565897 |
| 117 | MP0002822_catalepsy | 0.50823117 |
| 118 | MP0004885_abnormal_endolymph | 0.50468267 |
| 119 | MP0003300_gastrointestinal_ulcer | 0.50220947 |
| 120 | MP0003724_increased_susceptibility_to | 0.49221758 |
| 121 | MP0005409_darkened_coat_color | 0.48445288 |
| 122 | MP0002796_impaired_skin_barrier | 0.46155877 |
| 123 | MP0003959_abnormal_lean_body | 0.43639825 |
| 124 | MP0004264_abnormal_extraembryonic_tissu | 0.42854099 |
| 125 | MP0008874_decreased_physiological_sensi | 0.42234936 |
| 126 | MP0003075_altered_response_to | 0.37270962 |
| 127 | MP0005166_decreased_susceptibility_to | 0.36038641 |
| 128 | MP0010368_abnormal_lymphatic_system | 0.35918609 |
| 129 | MP0005448_abnormal_energy_balance | 0.35820578 |
| 130 | MP0005375_adipose_tissue_phenotype | 0.35574507 |
| 131 | MP0008872_abnormal_physiological_respon | 0.35127313 |
| 132 | MP0000747_muscle_weakness | 0.33641222 |
| 133 | MP0010234_abnormal_vibrissa_follicle | 0.32954960 |
| 134 | MP0002896_abnormal_bone_mineralization | 0.31988860 |
| 135 | MP0009115_abnormal_fat_cell | 0.31112696 |
| 136 | MP0009672_abnormal_birth_weight | 0.29992096 |
| 137 | MP0005330_cardiomyopathy | 0.28454964 |
| 138 | MP0005165_increased_susceptibility_to | 0.28087404 |
| 139 | MP0002069_abnormal_eating/drinking_beha | 0.27760911 |
| 140 | MP0008873_increased_physiological_sensi | 0.26995309 |
| 141 | MP0004782_abnormal_surfactant_physiolog | 0.26513745 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 7.36222122 |
| 2 | Nemaline bodies (HP:0003798) | 7.28095933 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.11516307 |
| 4 | Exercise-induced myalgia (HP:0003738) | 6.41905165 |
| 5 | Type 1 muscle fiber predominance (HP:0003803) | 5.88948999 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.77589587 |
| 7 | Gout (HP:0001997) | 5.34616510 |
| 8 | Intrahepatic cholestasis (HP:0001406) | 5.28735557 |
| 9 | Hyperglycinuria (HP:0003108) | 5.20270912 |
| 10 | Exercise-induced muscle cramps (HP:0003710) | 5.13419773 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.00941624 |
| 12 | Abnormality of glycine metabolism (HP:0010895) | 4.74113407 |
| 13 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.74113407 |
| 14 | Ketosis (HP:0001946) | 4.67829324 |
| 15 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.61845075 |
| 16 | Xanthomatosis (HP:0000991) | 4.58389800 |
| 17 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.55557730 |
| 18 | Deep venous thrombosis (HP:0002625) | 4.51004664 |
| 19 | Hyporeflexia of lower limbs (HP:0002600) | 4.44052878 |
| 20 | Hyperglycinemia (HP:0002154) | 4.42807158 |
| 21 | Rhabdomyolysis (HP:0003201) | 4.41515879 |
| 22 | EMG: myopathic abnormalities (HP:0003458) | 4.37787176 |
| 23 | Muscle fiber splitting (HP:0003555) | 4.31803931 |
| 24 | Hyperammonemia (HP:0001987) | 4.31549371 |
| 25 | Myopathic facies (HP:0002058) | 4.29230877 |
| 26 | Calf muscle hypertrophy (HP:0008981) | 4.23909266 |
| 27 | Abnormality of purine metabolism (HP:0004352) | 4.23319336 |
| 28 | Ketoacidosis (HP:0001993) | 4.22429982 |
| 29 | Myoglobinuria (HP:0002913) | 4.20041752 |
| 30 | Proximal tubulopathy (HP:0000114) | 4.18244004 |
| 31 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.06906070 |
| 32 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.06115506 |
| 33 | Asymmetric septal hypertrophy (HP:0001670) | 4.01010759 |
| 34 | Sudden death (HP:0001699) | 3.99244340 |
| 35 | Distal lower limb muscle weakness (HP:0009053) | 3.95300988 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.88650847 |
| 37 | Hyperuricemia (HP:0002149) | 3.86389422 |
| 38 | Increased purine levels (HP:0004368) | 3.86389422 |
| 39 | Bundle branch block (HP:0011710) | 3.80015577 |
| 40 | Abnormality of the calf musculature (HP:0001430) | 3.79567898 |
| 41 | Hypokalemic alkalosis (HP:0001949) | 3.78883709 |
| 42 | Increased circulating renin level (HP:0000848) | 3.75726355 |
| 43 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.75535451 |
| 44 | Generalized aminoaciduria (HP:0002909) | 3.74015955 |
| 45 | Abnormality of nucleobase metabolism (HP:0010932) | 3.72923696 |
| 46 | Prolonged partial thromboplastin time (HP:0003645) | 3.72241181 |
| 47 | Metabolic alkalosis (HP:0200114) | 3.59870339 |
| 48 | Complement deficiency (HP:0004431) | 3.59238474 |
| 49 | Alkalosis (HP:0001948) | 3.56496247 |
| 50 | Hypobetalipoproteinemia (HP:0003563) | 3.55488225 |
| 51 | Neck muscle weakness (HP:0000467) | 3.51195660 |
| 52 | Hyperactive renin-angiotensin system (HP:0000841) | 3.50547764 |
| 53 | Delayed CNS myelination (HP:0002188) | 3.48794070 |
| 54 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.48606273 |
| 55 | Hyperlipoproteinemia (HP:0010980) | 3.46238031 |
| 56 | Hypoglycemic coma (HP:0001325) | 3.40467698 |
| 57 | Distal arthrogryposis (HP:0005684) | 3.40428900 |
| 58 | Increased connective tissue (HP:0009025) | 3.32946795 |
| 59 | Hypomagnesemia (HP:0002917) | 3.29958874 |
| 60 | Round ear (HP:0100830) | 3.29389278 |
| 61 | Abnormal urine output (HP:0012590) | 3.29307637 |
| 62 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.29077824 |
| 63 | Subaortic stenosis (HP:0001682) | 3.29077824 |
| 64 | Polyuria (HP:0000103) | 3.28565396 |
| 65 | Difficulty running (HP:0009046) | 3.25659657 |
| 66 | Dicarboxylic aciduria (HP:0003215) | 3.18450874 |
| 67 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.18450874 |
| 68 | Abnormality of chloride homeostasis (HP:0011422) | 3.16578795 |
| 69 | Rimmed vacuoles (HP:0003805) | 3.16134421 |
| 70 | Joint hemorrhage (HP:0005261) | 3.14550867 |
| 71 | Metabolic acidosis (HP:0001942) | 3.14124430 |
| 72 | Vascular calcification (HP:0004934) | 3.13838943 |
| 73 | Abnormality of renal excretion (HP:0011036) | 3.12763635 |
| 74 | Abnormality of urine glucose concentration (HP:0011016) | 3.11269684 |
| 75 | Glycosuria (HP:0003076) | 3.11269684 |
| 76 | Increased variability in muscle fiber diameter (HP:0003557) | 3.10516674 |
| 77 | Fat malabsorption (HP:0002630) | 3.07320765 |
| 78 | Heart block (HP:0012722) | 3.06203622 |
| 79 | Ventricular tachycardia (HP:0004756) | 2.99830428 |
| 80 | Abnormality of serum amino acid levels (HP:0003112) | 2.95980727 |
| 81 | Abnormal atrioventricular conduction (HP:0005150) | 2.94846528 |
| 82 | Muscle stiffness (HP:0003552) | 2.90140954 |
| 83 | Lethargy (HP:0001254) | 2.90115219 |
| 84 | Epidermoid cyst (HP:0200040) | 2.88940176 |
| 85 | Abnormality of methionine metabolism (HP:0010901) | 2.85152585 |
| 86 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.84429449 |
| 87 | Ulnar deviation of the wrist (HP:0003049) | 2.83762244 |
| 88 | Hydroxyprolinuria (HP:0003080) | 2.77982809 |
| 89 | Abnormality of proline metabolism (HP:0010907) | 2.77982809 |
| 90 | Cardiovascular calcification (HP:0011915) | 2.77798300 |
| 91 | EMG: neuropathic changes (HP:0003445) | 2.75810638 |
| 92 | Hypolipoproteinemia (HP:0010981) | 2.75064564 |
| 93 | Atrioventricular block (HP:0001678) | 2.73356757 |
| 94 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.72132417 |
| 95 | Abnormality of magnesium homeostasis (HP:0004921) | 2.71434934 |
| 96 | Abnormality of the common coagulation pathway (HP:0010990) | 2.71259401 |
| 97 | Dilated cardiomyopathy (HP:0001644) | 2.67038022 |
| 98 | Vomiting (HP:0002013) | 2.66500553 |
| 99 | Conjugated hyperbilirubinemia (HP:0002908) | 2.60999004 |
| 100 | Malnutrition (HP:0004395) | 2.60949229 |
| 101 | Rickets (HP:0002748) | 2.58278897 |
| 102 | Enlarged kidneys (HP:0000105) | 2.56660802 |
| 103 | Abnormal drinking behavior (HP:0030082) | 2.55447458 |
| 104 | Polydipsia (HP:0001959) | 2.55447458 |
| 105 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.53998802 |
| 106 | Hyperbilirubinemia (HP:0002904) | 2.52628279 |
| 107 | Hypoalphalipoproteinemia (HP:0003233) | 2.52188369 |
| 108 | Bulbar palsy (HP:0001283) | 2.51845563 |
| 109 | Ragged-red muscle fibers (HP:0003200) | 2.50676779 |
| 110 | Frequent falls (HP:0002359) | 2.50591721 |
| 111 | Areflexia of lower limbs (HP:0002522) | 2.49989412 |
| 112 | Distal lower limb amyotrophy (HP:0008944) | 2.49502241 |
| 113 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.48872776 |
| 114 | Hyperphosphaturia (HP:0003109) | 2.45596089 |
| 115 | Abnormality of complement system (HP:0005339) | 2.45292236 |
| 116 | Sensorimotor neuropathy (HP:0007141) | 2.45206459 |
| 117 | Glomerulonephritis (HP:0000099) | 2.45084208 |
| 118 | Hepatocellular carcinoma (HP:0001402) | 2.44138702 |
| 119 | Lipoatrophy (HP:0100578) | 2.43617084 |
| 120 | Irritability (HP:0000737) | 2.43301294 |
| 121 | Neonatal onset (HP:0003623) | 2.43283536 |
| 122 | Nephrolithiasis (HP:0000787) | 2.41589102 |
| 123 | Renal tubular acidosis (HP:0001947) | 2.40126036 |
| 124 | Cerebral edema (HP:0002181) | 2.38216653 |
| 125 | Abnormality of the intrinsic pathway (HP:0010989) | 2.34826607 |
| 126 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.34539740 |
| 127 | Abnormality of renin-angiotensin system (HP:0000847) | 2.34483546 |
| 128 | Late onset (HP:0003584) | 2.33876117 |
| 129 | Renal salt wasting (HP:0000127) | 2.32709860 |
| 130 | Steatorrhea (HP:0002570) | 2.31359950 |
| 131 | Hyperaldosteronism (HP:0000859) | 2.31049343 |
| 132 | Generalized muscle weakness (HP:0003324) | 2.27335842 |
| 133 | Tetany (HP:0001281) | 2.26331446 |
| 134 | Myotonia (HP:0002486) | 2.24977126 |
| 135 | Abnormality of the foot musculature (HP:0001436) | 2.23212048 |
| 136 | Spastic diplegia (HP:0001264) | 2.21076447 |
| 137 | Ventricular arrhythmia (HP:0004308) | 2.19946215 |
| 138 | Abnormal urine phosphate concentration (HP:0012599) | 2.19694513 |
| 139 | Hypophosphatemia (HP:0002148) | 2.17469159 |
| 140 | Confusion (HP:0001289) | 2.15334376 |
| 141 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.14964535 |
| 142 | Foot dorsiflexor weakness (HP:0009027) | 2.12772922 |
| 143 | Systemic lupus erythematosus (HP:0002725) | 2.10408966 |
| 144 | Hypercholesterolemia (HP:0003124) | 2.09527714 |
| 145 | Pancreatitis (HP:0001733) | 2.08005560 |
| 146 | Methylmalonic aciduria (HP:0012120) | 2.07154157 |
| 147 | Gowers sign (HP:0003391) | 2.05946755 |
| 148 | Right ventricular cardiomyopathy (HP:0011663) | 2.05082663 |
| 149 | Cholelithiasis (HP:0001081) | 2.04387250 |
| 150 | Calcaneovalgus deformity (HP:0001848) | 2.01284287 |
| 151 | Nausea (HP:0002018) | 2.00338844 |
| 152 | Hypophosphatemic rickets (HP:0004912) | 1.99869213 |
| 153 | Increased serum pyruvate (HP:0003542) | 1.98104394 |
| 154 | Syncope (HP:0001279) | 1.97961370 |
| 155 | Malignant hyperthermia (HP:0002047) | 1.97421127 |
| 156 | Hemorrhage of the eye (HP:0011885) | 1.96535478 |
| 157 | Elevated alkaline phosphatase (HP:0003155) | 1.95692274 |
| 158 | Absent phalangeal crease (HP:0006109) | 1.93299989 |
| 159 | Ventricular fibrillation (HP:0001663) | 1.92951929 |
| 160 | Progressive muscle weakness (HP:0003323) | 1.92204995 |
| 161 | Scapular winging (HP:0003691) | 1.92091876 |
| 162 | Oligomenorrhea (HP:0000876) | 1.91702136 |
| 163 | Hypoglycemic seizures (HP:0002173) | 1.91252684 |
| 164 | Abnormality of glycolysis (HP:0004366) | 1.90071621 |
| 165 | Hyperkalemia (HP:0002153) | 1.88343275 |
| 166 | Myocardial infarction (HP:0001658) | 1.87835422 |
| 167 | Difficulty climbing stairs (HP:0003551) | 1.85997231 |
| 168 | Abnormality of the Achilles tendon (HP:0005109) | 1.84111306 |
| 169 | Abnormal gallbladder morphology (HP:0012437) | 1.81127388 |
| 170 | Increased muscle lipid content (HP:0009058) | 1.80846341 |
| 171 | Lower limb amyotrophy (HP:0007210) | 1.79856714 |
| 172 | Limb-girdle muscle atrophy (HP:0003797) | 1.74796054 |
| 173 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.72757642 |
| 174 | Deformed tarsal bones (HP:0008119) | 1.72415188 |
| 175 | Atrial fibrillation (HP:0005110) | 1.67847704 |
| 176 | Nephritis (HP:0000123) | 1.65434684 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.34714307 |
| 2 | WNK4 | 5.91922676 |
| 3 | TTN | 5.57355304 |
| 4 | WNK3 | 5.15651408 |
| 5 | OXSR1 | 4.69298497 |
| 6 | PHKG1 | 4.52847133 |
| 7 | FGFR4 | 3.06213730 |
| 8 | ERN1 | 2.76052255 |
| 9 | STK39 | 2.60652306 |
| 10 | SIK1 | 2.39054559 |
| 11 | STK38L | 2.37466730 |
| 12 | INSRR | 2.24280735 |
| 13 | MUSK | 1.92134666 |
| 14 | PDK4 | 1.88600314 |
| 15 | PDK3 | 1.88600314 |
| 16 | MST1R | 1.87096187 |
| 17 | ERBB4 | 1.84627160 |
| 18 | EEF2K | 1.81287649 |
| 19 | MAPKAPK3 | 1.71899151 |
| 20 | PINK1 | 1.68993607 |
| 21 | DMPK | 1.55772329 |
| 22 | ICK | 1.54601610 |
| 23 | PRPF4B | 1.54178876 |
| 24 | SGK494 | 1.50678875 |
| 25 | SGK223 | 1.50678875 |
| 26 | TAOK3 | 1.47025352 |
| 27 | MAP2K4 | 1.42771358 |
| 28 | MAPK11 | 1.29517959 |
| 29 | PDK2 | 1.29151892 |
| 30 | TRIB3 | 1.26181583 |
| 31 | MAP3K7 | 1.23904553 |
| 32 | PIK3CA | 1.21998619 |
| 33 | LATS1 | 1.20407376 |
| 34 | EPHB1 | 1.17462610 |
| 35 | NEK1 | 1.14524445 |
| 36 | FRK | 1.12149984 |
| 37 | SGK3 | 1.09629729 |
| 38 | ABL2 | 1.07279652 |
| 39 | PIK3CG | 1.05314406 |
| 40 | TIE1 | 1.04060636 |
| 41 | PRKAA2 | 1.02167535 |
| 42 | WNK1 | 1.02138357 |
| 43 | SGK2 | 1.01393235 |
| 44 | STK38 | 0.98692642 |
| 45 | PTK6 | 0.96374245 |
| 46 | NEK9 | 0.93447690 |
| 47 | GRK6 | 0.92817686 |
| 48 | LMTK2 | 0.91937402 |
| 49 | PRKD3 | 0.91782573 |
| 50 | ARAF | 0.87982530 |
| 51 | MAP3K3 | 0.87633446 |
| 52 | LATS2 | 0.86135815 |
| 53 | LIMK1 | 0.84859194 |
| 54 | TRPM7 | 0.84366142 |
| 55 | GSK3A | 0.83933386 |
| 56 | TAOK2 | 0.83471737 |
| 57 | IRAK3 | 0.83046126 |
| 58 | KSR2 | 0.81670439 |
| 59 | MAPK15 | 0.79644720 |
| 60 | PRKAA1 | 0.77347331 |
| 61 | TGFBR2 | 0.76825993 |
| 62 | MAP2K3 | 0.76233866 |
| 63 | TYK2 | 0.75009410 |
| 64 | TESK1 | 0.74266237 |
| 65 | MAP3K14 | 0.73369497 |
| 66 | CAMK2D | 0.72861810 |
| 67 | JAK2 | 0.71560722 |
| 68 | MAP3K1 | 0.71184220 |
| 69 | MYLK | 0.70752551 |
| 70 | FGFR2 | 0.69967910 |
| 71 | PKN2 | 0.69485931 |
| 72 | PDPK1 | 0.69476403 |
| 73 | PRKCZ | 0.68960283 |
| 74 | EPHA2 | 0.67913379 |
| 75 | MET | 0.65632448 |
| 76 | AKT2 | 0.65108707 |
| 77 | DYRK1B | 0.64510422 |
| 78 | DAPK2 | 0.62543451 |
| 79 | PRKD1 | 0.61733241 |
| 80 | CAMK1 | 0.61710730 |
| 81 | PTK2 | 0.60584399 |
| 82 | SMG1 | 0.60418200 |
| 83 | MARK1 | 0.59678319 |
| 84 | MAPK12 | 0.59030671 |
| 85 | FLT3 | 0.57445049 |
| 86 | MOS | 0.56155090 |
| 87 | PRKACG | 0.55147198 |
| 88 | CAMK2B | 0.52787282 |
| 89 | CDC42BPA | 0.52448224 |
| 90 | ZAP70 | 0.51133708 |
| 91 | MAPK4 | 0.49350480 |
| 92 | RPS6KL1 | 0.48687046 |
| 93 | RPS6KC1 | 0.48687046 |
| 94 | CAMK2G | 0.48684715 |
| 95 | TAOK1 | 0.48191050 |
| 96 | PAK3 | 0.48125712 |
| 97 | JAK1 | 0.48020664 |
| 98 | MARK2 | 0.47090367 |
| 99 | IRAK2 | 0.46474660 |
| 100 | PRKG1 | 0.45342129 |
| 101 | MTOR | 0.43242710 |
| 102 | ERBB2 | 0.43146439 |
| 103 | PDK1 | 0.43009920 |
| 104 | ROCK1 | 0.42724106 |
| 105 | NME1 | 0.41942139 |
| 106 | TNK2 | 0.40399832 |
| 107 | IRAK1 | 0.39857708 |
| 108 | TBK1 | 0.39852269 |
| 109 | KDR | 0.39806314 |
| 110 | RPS6KA2 | 0.39657860 |
| 111 | LRRK2 | 0.39499798 |
| 112 | MAP2K6 | 0.38724043 |
| 113 | SGK1 | 0.38654895 |
| 114 | RET | 0.36610438 |
| 115 | OBSCN | 0.36517731 |
| 116 | MAP3K9 | 0.35333240 |
| 117 | RIPK1 | 0.35269806 |
| 118 | CAMK1D | 0.34060910 |
| 119 | RPS6KA6 | 0.33832632 |
| 120 | PRKCQ | 0.31995327 |
| 121 | RPS6KA3 | 0.31907309 |
| 122 | MAP3K11 | 0.31510485 |
| 123 | CAMK2A | 0.31360991 |
| 124 | CAMK1G | 0.31004825 |
| 125 | FER | 0.29961052 |
| 126 | MAP3K5 | 0.29361999 |
| 127 | CSK | 0.28902652 |
| 128 | CCNB1 | 0.28854386 |
| 129 | PRKG2 | 0.28317719 |
| 130 | PRKCH | 0.27984510 |
| 131 | MAP2K1 | 0.25860879 |
| 132 | CSNK1G1 | 0.25075616 |
| 133 | MAP3K6 | 0.24643357 |
| 134 | PRKCA | 0.24081682 |
| 135 | IGF1R | 0.23585957 |
| 136 | PKN1 | 0.23567083 |
| 137 | EPHA3 | 0.22984153 |
| 138 | PRKACA | 0.22584203 |
| 139 | MAPK7 | 0.20361468 |
| 140 | PRKCG | 0.19940249 |
| 141 | EPHA4 | 0.19629299 |
| 142 | MAP3K13 | 0.19306471 |
| 143 | FGFR3 | 0.17716933 |
| 144 | PRKCD | 0.17015951 |
| 145 | CAMK4 | 0.16855055 |
| 146 | MAP3K2 | 0.15484189 |
| 147 | STK11 | 0.13959703 |
| 148 | PHKG2 | 0.13557726 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.55604976 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.38165137 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.99335344 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.99285725 |
| 5 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.96724388 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.94209840 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.73229378 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.70149871 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.65595478 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.65210994 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.56093173 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.49055740 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.44484357 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.43289459 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.43146617 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.41108496 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.15793705 |
| 18 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.05294454 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.01291589 |
| 20 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.94461688 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.80175219 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.79744155 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.78219806 |
| 24 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.75415036 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.70401028 |
| 26 | * Pyruvate metabolism_Homo sapiens_hsa00620 | 1.69782276 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.62897234 |
| 28 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.62587149 |
| 29 | Bile secretion_Homo sapiens_hsa04976 | 1.58286813 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.55595669 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.52860538 |
| 32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.50980933 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.50539151 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.48014103 |
| 35 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.47956615 |
| 36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.43456687 |
| 37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.41491957 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.40396487 |
| 39 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.38021024 |
| 40 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.34842915 |
| 41 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.34549159 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34216095 |
| 43 | Retinol metabolism_Homo sapiens_hsa00830 | 1.31543898 |
| 44 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.29658644 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.26037480 |
| 46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.25929345 |
| 47 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.20702014 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.15056830 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14895324 |
| 50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.14001885 |
| 51 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.12547238 |
| 52 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.11669198 |
| 53 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.07181766 |
| 54 | Lysine degradation_Homo sapiens_hsa00310 | 1.01879449 |
| 55 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.00416054 |
| 56 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.00088894 |
| 57 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.93622386 |
| 58 | ABC transporters_Homo sapiens_hsa02010 | 0.93172924 |
| 59 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.89701832 |
| 60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.87995867 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.87865003 |
| 62 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.79101242 |
| 63 | Sulfur relay system_Homo sapiens_hsa04122 | 0.75008091 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74881870 |
| 65 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.73842830 |
| 66 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.73038049 |
| 67 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.69624307 |
| 68 | Circadian rhythm_Homo sapiens_hsa04710 | 0.66933823 |
| 69 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.64002687 |
| 70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56536988 |
| 71 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54082770 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48699103 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47269175 |
| 74 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.35487742 |
| 75 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.35228996 |
| 76 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.33422839 |
| 77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.28709097 |
| 78 | Other glycan degradation_Homo sapiens_hsa00511 | 0.27597860 |
| 79 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.27501844 |
| 80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.26960991 |
| 81 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.26351798 |
| 82 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.25884818 |
| 83 | Renin secretion_Homo sapiens_hsa04924 | 0.24442754 |
| 84 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.23713478 |
| 85 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23650818 |
| 86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23455133 |
| 87 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.23108549 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.21812859 |
| 89 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20285368 |
| 90 | Mineral absorption_Homo sapiens_hsa04978 | 0.19042614 |
| 91 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.14554015 |
| 92 | Pertussis_Homo sapiens_hsa05133 | 0.14173777 |
| 93 | Amoebiasis_Homo sapiens_hsa05146 | 0.13809048 |
| 94 | Tight junction_Homo sapiens_hsa04530 | 0.13637080 |
| 95 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.13246477 |
| 96 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.12527470 |
| 97 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.12241179 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.12044725 |
| 99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.11700771 |
| 100 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.11060007 |
| 101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.10346725 |
| 102 | Prion diseases_Homo sapiens_hsa05020 | 0.09627820 |
| 103 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08829460 |
| 104 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.08722165 |
| 105 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.08388711 |
| 106 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.07683513 |
| 107 | Lysosome_Homo sapiens_hsa04142 | 0.07028691 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.05985927 |
| 109 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.05192619 |
| 110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.04971882 |
| 111 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04723012 |
| 112 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.02316715 |
| 113 | Hepatitis C_Homo sapiens_hsa05160 | -0.1665335 |
| 114 | Alzheimers disease_Homo sapiens_hsa05010 | -0.1439558 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1306810 |
| 116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1130003 |
| 117 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0623080 |
| 118 | Parkinsons disease_Homo sapiens_hsa05012 | -0.0431914 |
| 119 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | -0.0184929 |
| 120 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.0090002 |

